看消化科中山哪个医院看的好-【中山华都肛肠医院】,gUfTOBOs,中山屁股肛门红肿出血怎么了,中山检查肛裂得多少钱,中山如厕有血,中山痣疮的病因,中山市华都医院在哪好不好,中山市痔疮
看消化科中山哪个医院看的好中山痔疮激光手术,中山痔疮大便后出血,中山哪家医院治疗肛肠正规,中山肛泰医院医生,中山做无痛肠镜需要多少钱,中山痔疮这么办,中山菊花上长了个肉球
New York, Sept. 23 (Xinhua) -- A Chinese scientist was presented a prestigious U.S. award on Friday for the discovery of artemisinin, a drug therapy for malaria that has saved millions of lives across the globe, especially in the developing world.Pharmacologist Tu Youyou, 81, became the first scientist on the Chinese mainland to win Lasker Award, known as "America's Nobels" for their knack of gaining future recognition by the Nobel committee.Tu, a scientist at the China Academy of Chinese Medical Sciences in Beijing, pioneered a new approach to malaria treatment that has benefited hundreds of millions of people and promises to benefit many times more. By applying modern techniques and rigor to a heritage provided by 5000 years of Chinese traditional practitioners, she has delivered its riches into the 21st century."Not often in the history of clinical medicine can we celebrate a discovery that has eased the pain and distress of hundreds of millions of people and saved the lives of countless numbers of people, particularly children, in over 100 countries," Lucy Shapiro, a member of the award jury and professor of Stanford University, said while describing Tu' s discovery.Shapiro said the discovery, chemical identification, and validation of artemisinin, a highly effective anti-malarial drug, is largely due to the "scientific insight, vision and dogged determination" of Professor Tu and her team. She thought Professor Tu's work has provided the world with arguably the most important pharmaceutical intervention in the last half century."The discovery of artemisinin is a gift to mankind from traditional Chinese medicine," Tu said while receiving the award. "Continuous exploration and development of traditional medicine will, without doubt, bring more medicines to the world."
WASHINGTON, July 12 (Xinhua) -- Two U.S. astronauts stepped out the International Space Station on Tuesday to retrieve a failed ammonia pump, which is the last spacewalk of the shuttle era, NASA announced.Space station astronauts Mike Fossum and Ron Garan completed the six-hour, 31-minute spacewalk at 3:53 p.m. EDT (1953 GMT). The duo retrieved a pump module from an external stowage platform on station and store it in shuttle Atlantis' cargo bay for return to Earth.The pump module failed in 2010, shutting down half of the space station's cooling system. Engineers will evaluate the module to determine the cause of the failure and plan to refurbish it for use as a spare.The astronauts also attached a Robotic Refueling Module experiment to the space station, which aims to test technologies for repairing and refueling satellites in space.It was the 249th spacewalk by U.S. astronauts and the 160th spacewalk in support of space station assembly and maintenance, totaling 1009 hours, nine minutes.Atlantis lifted off on Friday morning from Kennedy Space Center in Florida, on the 135th and final flight in NASA's shuttle program. Its return to the earth later this month will mark the end of the 30-year shuttle program.
BEIJING, Sept. 26 (Xinhuanet) -- Although it is home to traditional Chinese medicine (TCM), China must do much more to improve its academic research capacity for acupuncture, a form of TCM, to take the lead worldwide on both the academic and clinical sides.At present, among all academic theses on acupuncture indexed by the Science Citation Index (SCI), a leading world thesis index system, only 5 percent are from the Chinese mainland, according to Wang Linpeng, the director of the acupuncture and moxibustion center of the Beijing Hospital of Traditional Chinese Medicine, which is affiliated with the Capital Medical University.Although Chinese acupuncturists absolutely excel worldwide in clinical practice, "they are not as good as their foreign peers in academic capacity, particularly Western-style research methods and lab experiment design," he told China Daily on Friday during the 2011 International Symposium on Acupuncture. A patient suffering from facial paralysis receives acupuncture treatment at a hospital in Nanjing, the capital of Jiangsu province, on Dec 6, 2010.Studies by TCM practitioners - including acupuncturists - largely focus on their area of specialization, and few are in line with global interest in the medical science that has been proven effective over thousands of years, he said."Chinese TCM practitioners are very good at treating conditions, but they are clumsy at showing how and why it really works in an internationally accepted 'language' and 'manner'," said Gao Sihua, chancellor of the Beijing University of Chinese Medicine."It's especially true in TCM circles, where few Chinese practitioners would regularly follow international academic articles and research trends," Wang said.Measured by the number of articles on acupuncture indexed by SCI, the US and European countries lead globally, he said.
BEIJING, July 22 (Xinhuanet) -- Regulation is needed to govern rapidly expanding research in animals containing human tissue or genes, according to the Britain's Academy of Medical Sciences.Using animals with limited humanized traits is not new. Genetically engineered mice containing human DNA are already a mainstay of research into new drugs for diseases like cancer.For instance, Chinese scientists have already introduced human stem cells into goat fetuses and U.S. researchers have studied the idea of creating a mouse with human brain cells.But Martin Bobrow, a professor of medical genetics at the University of Cambridge, who led the Academy's working group, said there were three areas of particular concern."Where people begin to worry is when you get to the brain, to the germ cells, and to the sort of central features that help us recognize what is a person, like skin texture, facial shape and speech," he said.His report recommends that government should put in place a national expert body, working within the existing system for regulating animal research, to oversee such sensitive areas.British ministers said they welcomed the report and would consider its recommendations carefully.
BEIJING, Sept. 26 (Xinhua) -- Nobel laureates on Monday cast doubt on a European experiment that purportedly demonstrated the ability of neutrinos to move faster than the speed of light.They made the remarks in Beijing prior to a forum for Nobel laureates."I'm willing to bet money that it's not correct," said Professor George Smoot III, winner of the 2006 Nobel Prize in Physics and a professor at University of California, Berkeley, referring to an experiment result claiming that particles apparently travel faster than light.The experiment reported an anomaly in the flight time of neutrinos, or electrically neutral subatomic particles, from the European Center for Nuclear Research (CERN) in Switzerland to a laboratory located 730 kilometers away in Italy.Particles were clocked transmitting at a speed of 300,006 kilometers per second, about 60 nanoseconds faster than the speed of light.Smoot said that the claims "did not make sense" and should be verified by other scientists first."There are many distortions in physics. You have to have a very high standard to see if something is truly correct," he said.The unverified findings were published on Sept. 22 in the scientific journal Nature. European researchers working in a team called OPERA (Oscillation Project with Emulsion-Racking Apparatus) projected masses of neutrinos from CERN and then collected the particles using a massive detector in Gran Sasso, south of Rome.Other scientists, as well as the OPERA team themselves, have voiced doubts regarding the experiment's results.The findings, CERN claims, could pose far-reaching potential consequences once verified.If correct, the results would bring Einstein's theory of special relativity into question. Under this theory, a physical object cannot travel faster than the speed of light in a vacuum."If really it is right, we have to rethink everything we know," said Chris Llewellyn Smith, former director of CERN.Smith claimed the unprecedented discovery was too exceptional to find proof."If somebody makes a very exceptional claim, then very exceptional proof would need to come from another experiment, saying the same thing. But we don't have the other thing," Smith said.Carlos Rubbia, a Nobel Laureate who won the prize for physics in 1984, is in charge of a team of more than 100 scientists at CERN."What it is pretending to find, in my view, is unbelievably surprising," Rubbia said."Frankly, I have the feeling that this is still a very experimental consideration," Rubbia said.He also believes that revealing the findings to the public was a mistake as it remained an experimental process and no conclusion could be drawn without the results of another experiment.Despite the possibility of verification, Einstein's special theory of relativity will remain valid."I will be very, very surprised that, at last, Einstein will not be the winner," Rubbia said.To achieve a breakthrough, Rubbia has urged for more joint cooperation on verifying the test results. International cooperation on this issue "is a must.""It requires coordination from all nations," said Rubbia.The 2011 Nobel Laureates Beijing Forum will be held from Sept. 28 to 30 under a theme of "innovation and development."